Immunic (IMUX) Institutional Ownership $0.82 -0.05 (-5.75%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.82 +0.00 (+0.37%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Immunic (NASDAQ:IMUX)CurrentInstitutional OwnershipPercentage51.82%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$8.22MNumber ofInstitutional Sellers(last 12 months)12TotalInstitutional Outflows(last 12 months)$12.24M Get IMUX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunic stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data IMUX Institutional Buying and Selling by Quarter Immunic Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Boothbay Fund Management LLC240,873$168K0.0%-43.3%0.244% 8/15/2025 BVF Inc. IL7,652,972$5.34M0.2%-14.0%7.758% 8/15/2025 683 Capital Management LLC62,458$44K0.0%-93.1%0.063% 8/13/2025 Marshall Wace LLP49,991$35K0.0%-91.1%0.051% 7/24/2025 Aberdeen Group plc8,243,941$5.75M0.0%+678.1%8.604% 5/20/2025 Focus Partners Wealth2,583,457$2.82M0.0%+19.1%2.696% 5/19/2025 Jane Street Group LLC207,401$226K0.0%+279.3%0.216% 5/16/2025 683 Capital Management LLC900,000$981K0.1%+28.6%0.939% 5/13/2025 Aberdeen Group plc1,059,484$1.16M0.0%N/A1.106% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.120,027$131K0.0%-24.6%0.125% Get the Latest News and Ratings for IMUX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. 5/7/2025 HB Wealth Management LLC52,400$57K0.0%-33.2%0.055% 2/17/2025 Two Sigma Investments LP157,204$157K0.0%-40.2%0.175% 2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC204,579$205K0.0%+90.0%0.227% 2/17/2025 Millennium Management LLC579,683$580K0.0%+480.6%0.644% 2/17/2025 Janus Henderson Group PLC2,689,082$2.69M0.0%-47.3%2.985% 2/17/2025 Focus Partners Wealth2,168,353$2.17M0.0%+1.1%2.407% 2/17/2025 Bridgeway Capital Management LLC215,000$215K0.0%+11.5%0.239% 2/17/2025 683 Capital Management LLC700,000$700K0.0%+2.2%0.777% 2/14/2025 Jane Street Group LLC54,675$55K0.0%-22.2%0.061% 2/14/2025 Adage Capital Partners GP L.L.C.1,398,600$1.40M0.0%-75.0%1.553% 2/13/2025 Marshall Wace LLP417,883$418K0.0%-10.4%0.464% 2/13/2025 Barclays PLC84,299$84K0.0%N/A0.094% 2/13/2025 Renaissance Technologies LLC566,623$567K0.0%+45.6%0.629% 2/13/2025 Invesco Ltd.36,811$37K0.0%N/A0.041% 1/15/2025 HB Wealth Management LLC78,400$81K0.0%N/A0.087% 11/20/2024 Virtu Financial LLC30,359$50K0.0%N/A0.034% 11/15/2024 XTX Topco Ltd28,957$48K0.0%-53.4%0.032% 11/15/2024 Jane Street Group LLC70,299$116K0.0%+121.4%0.078% 11/15/2024 State Street Corp167,145$276K0.0%+7.5%0.186% 11/15/2024 Janus Henderson Group PLC5,099,278$8.44M0.0%-27.9%5.661% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.102,257$169K0.0%+70.8%0.114% 11/5/2024 GSA Capital Partners LLP32,766$54K0.0%-71.9%0.036% 8/14/2024 Marshall Wace LLP39,621$44K0.0%-20.0%0.044% 8/9/2024 Renaissance Technologies LLC291,087$323K0.0%-61.0%0.323% 5/20/2024 Virtu Financial LLC19,088$25K0.0%N/A0.021% 5/17/2024 Ikarian Capital LLC1,612,378$2.13M0.2%+258.3%1.790% 5/16/2024 Janus Henderson Group PLC6,993,007$9.27M0.0%N/A7.763% 5/16/2024 BVF Inc. IL8,902,972$11.75M0.3%N/A9.884% 5/10/2024 Acadian Asset Management LLC239,962$316K0.0%-57.1%0.266% 5/10/2024 Vanguard Group Inc.3,394,047$4.48M0.0%+100.7%3.768% Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged.4/23/2024 Summit Trail Advisors LLC18,600$25K0.0%N/A0.021% 2/22/2024 Sierra Summit Advisors LLC324,829$487K0.1%N/A0.719% 2/7/2024Gratus Capital LLC1,941,454$2.91M0.2%+15.1%4.300% 1/12/2024Sweet Financial Partners LLC29,829$45K0.0%N/A0.066% 11/15/2023 RTW Investments LP4,335,255$6.37M0.1%+0.9%9.720% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.24,773$36K0.0%-77.0%0.056% 11/13/2023 Acadian Asset Management LLC757,250$1.11M0.0%+26.8%1.698% 11/9/2023Cowen AND Company LLC317,059$466K0.0%-11.4%0.711% 11/9/2023Innovis Asset Management LLC272,457$401K0.2%+46.3%0.611% 8/14/2023 Deep Track Capital LP308,314$774K0.0%-87.8%0.691% 8/8/2023 Balboa Wealth Partners12,000$30K0.0%N/A0.027% 8/7/2023 Acadian Asset Management LLC597,277$1.50M0.0%+439.2%1.339% 8/3/2023Innovis Asset Management LLC186,240$467K0.2%+130.6%0.419% 8/3/2023Gratus Capital LLC1,678,793$4.21M0.3%+1.4%3.781% 7/27/2023 Virtu Financial LLC67,424$169K0.0%N/A0.152% 7/24/2023 Vontobel Holding Ltd.10,000$25K0.0%N/A0.023% 5/15/2023 Logos Global Management LP421,184$628K0.1%N/A0.949% 5/15/2023 RTW Investments LP4,294,459$6.40M0.1%+11.2%9.671% 5/10/2023Innovis Asset Management LLC80,773$120K0.0%N/A0.182% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.86,907$129K0.0%N/A0.196% 5/9/2023Cowen AND Company LLC357,855$533K0.1%-54.8%0.806% 4/20/2023Gratus Capital LLC1,655,405$2.47M0.2%-0.8%3.728% 2/14/2023 RA Capital Management L.P.632,184$885K0.0%N/A1.425% 2/13/2023 Vivo Capital LLC632,184$833K0.1%N/A1.425% 2/13/2023 Artal Group S.A.1,274,713$1.79M0.1%+82.1%2.874% 2/9/2023Cowen AND Company LLC791,024$1.11M0.1%-34.1%1.783% 1/27/2023Gratus Capital LLC1,668,294$2.34M0.2%+121.5%3.761% 11/15/2022 Parkman Healthcare Partners LLC657,643$2.08M0.6%+1.2%1.675% 11/14/2022 Lynx1 Capital Management LP1,072,288$3.39M3.1%-2.9%2.731% 11/14/2022 Verition Fund Management LLC698,934$2.21M0.0%+14.6%1.780% 11/14/2022Ergoteles LLC24,725$78K0.0%-72.6%0.063% 11/14/2022 UBS Oconnor LLC197,988$626K0.0%-14.9%0.504% 11/4/2022Gratus Capital LLC753,190$2.38M0.3%N/A2.464% 10/25/2022 Denali Advisors LLC17,000$54K0.0%N/A0.056% 8/30/2022 Verition Fund Management LLC609,765$2.12M0.0%+331.5%1.995% 8/16/2022 Corton Capital Inc.12,142$42K0.0%N/A0.040% 8/16/2022Delphia USA Inc.13,181$46K0.0%N/A0.043% 8/15/2022 Point72 Asset Management L.P.1,325,000$4.60M0.0%+82.8%4.335% 8/5/2022Cowen AND Company LLC1,200,691$4.17M0.4%-6.3%3.932% 6/2/2022 Verition Fund Management LLC141,319$1.60M0.0%-26.2%0.463% 5/17/2022 RTW Investments LP2,705,513$30.57M0.6%+57.7%8.859% 5/17/2022Endurant Capital Management LP130,567$1.48M0.4%-29.2%0.428% 5/13/2022 Parkman Healthcare Partners LLC1,089,251$12.31M3.6%+11.8%3.567% 5/13/2022 DLD Asset Management LP50,000$565K0.0%N/A0.164% 4/21/2022 Zurcher Kantonalbank Zurich Cantonalbank3,031$34K0.0%N/A0.011% 4/18/2022Golden Green Inc.32,649$369K0.3%-49.7%0.117% 2/16/2022Ghost Tree Capital LLC165,000$1.58M0.6%-37.7%0.629% 2/14/2022 Altium Capital Management LP317,000$3.03M0.8%+890.0%1.208% 2/14/2022 Point72 Asset Management L.P.725,000$6.94M0.0%+16.0%2.762% 2/14/2022 Soleus Capital Management L.P.175,000$1.68M0.2%N/A0.667% This stock could leave NVDA in the dust (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here.2/11/2022 KCK LTD.69,704$667K0.5%N/A0.266% 2/9/2022 Alps Advisors Inc.30,370$291K0.0%-5.6%0.116% 2/4/2022 Otter Creek Advisors LLC120,000$1.15M0.7%+20.0%0.457% 1/21/2022Golden Green Inc.64,910$621K0.5%-25.5%0.247% 11/17/2021 Altium Capital Management LP32,021$320K0.1%N/A0.122% 11/16/2021 Schonfeld Strategic Advisors LLC54,400$482K0.0%+6.9%0.207% 11/16/2021 Two Sigma Advisers LP165,218$1.46M0.0%+1.8%0.629% 11/16/2021 Two Sigma Investments LP140,067$1.24M0.0%-9.1%0.534% 11/16/2021 Millennium Management LLC495,171$4.38M0.0%+106.7%1.886% 11/15/2021 Point72 Asset Management L.P.625,000$5.53M0.0%N/A2.381% (Data available from 1/1/2016 forward) IMUX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IMUX shares? During the previous two years, 32 institutional investors and hedge funds held shares of Immunic. The most heavily invested institutionals were RTW Investments LP ($6.37M), Aberdeen Group plc ($5.75M), BVF Inc. IL ($5.34M), Vanguard Group Inc. ($4.48M), Gratus Capital LLC ($2.91M), Focus Partners Wealth ($2.82M), and Janus Henderson Group PLC ($2.69M).Learn more on Immunic's institutional investors. What percentage of Immunic's stock is owned by institutional investors? 51.82% of Immunic's stock is owned by institutional investors. Learn more on IMUX's institutional investor holdings. Which institutional investors have been buying Immunic's stock? Of the 25 institutional investors that purchased Immunic's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($8.90M), Aberdeen Group plc ($8.24M), Janus Henderson Group PLC ($6.99M), Vanguard Group Inc. ($1.70M), Ikarian Capital LLC ($1.16M), Millennium Management LLC ($479.85K), and Focus Partners Wealth ($438.71K). How much institutional buying is happening at Immunic? Institutional investors have bought a total of 10,149,659 shares in the last 24 months. This purchase volume represents approximately $8.22M in transactions. Which of Immunic's major shareholders have been selling company stock? Of the 12 institutional investors that sold Immunic's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Janus Henderson Group PLC ($4.38M), Adage Capital Partners GP L.L.C. ($4.20M), BVF Inc. IL ($1.25M), 683 Capital Management LLC ($837.54K), Marshall Wace LLP ($561.96K), Boothbay Fund Management LLC ($184.30K), and Two Sigma Investments LP ($105.67K). How much institutional selling is happening at Immunic? Institutional investors have sold a total of 11,717,988 shares in the last 24 months. This volume of shares sold represents approximately $12.24M in transactions. Related Companies ADC Therapeutics Major Shareholders Fulcrum Therapeutics Major Shareholders Canopy Growth Major Shareholders Aldeyra Therapeutics Major Shareholders Benitec Biopharma Major Shareholders CytomX Therapeutics Major Shareholders Amarin Major Shareholders Candel Therapeutics Major Shareholders 4D Molecular Therapeutics Major Shareholders DiaMedica Therapeutics Major Shareholders This page (NASDAQ:IMUX) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
